Kenneth A Iczkowski
Overview
Explore the profile of Kenneth A Iczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2231
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masud N, Aldahish A, Iczkowski K, Kale A, Shah G
Int J Oncol
. 2025 Feb;
66(3).
PMID: 39917995
Following the publication of this paper, a concerned reader drew to the attention of the Editorial Office that, for the photomicrographs shown in Fig. 2B on p. 8, the same...
2.
Sangoi A, Shahabi A, Hirsch M, Kao C, Deebajah M, Barletta J, et al.
Am J Clin Pathol
. 2024 Dec;
PMID: 39720998
Objectives: Urothelial carcinoma in situ (CIS) with early papillary formation is terminology sometimes used to suggest incipient high-grade papillary urothelial carcinoma (PUC) but may lead to confusion between true CIS...
3.
Bernhardt M, Weinhold L, Bremmer F, Chan E, Cheng L, Collins K, et al.
Histopathology
. 2024 Nov;
86(4):627-639.
PMID: 39610035
Aims: Tumour content in prostatic biopsies is an important indicator of prostate cancer volume and patient prognosis. Consequently, guidelines typically recommend reporting it as a percentage or linear length (mm)....
4.
Yan H, Mao A, Li D, Perez-Baena M, Jimenez-Navas A, Wang D, et al.
medRxiv
. 2024 Nov;
PMID: 39606414
Significance: We describe a highly accurate CMB model to predict the therapeutic benefit in prostate cancer patients and uncover the complex interplay between genetic variants and CMBs on NADT resistance....
5.
Shakroo Y, Seabury Jr C, Iczkowski K, Nelson K, Qian J, Ramnani D
Pathol Res Pract
. 2024 Nov;
264:155718.
PMID: 39541765
While most prostate cancer is sporadic, evidence suggests that a significant minority of cases have a hereditary component, and germline variants may play a role in this heritability. In this...
6.
Varma M, Amin M, Berney D, Comperat E, Epstein J, Iczkowski K, et al.
Histopathology
. 2024 Sep;
85(5):746-747.
PMID: 39252552
No abstract available.
7.
8.
Sanders J, Iczkowski K, Shah G
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123347
The purpose of this study was to assess the efficacy, specificity, and predictive value of a newly discovered biomarker, Zinc finger-like1 protein (referred to as neuroendocrine marker, NEM) for the...
9.
Lobo A, Collins K, Kaushal S, Acosta A, Akgul M, Adhya A, et al.
Histopathology
. 2024 Jul;
85(5):748-759.
PMID: 39075659
Aims: Urothelial carcinoma (UC) demonstrates significant molecular and histologic heterogeneity. The WHO 2022 classification has hinted at adding molecular signatures to the morphologic diagnosis. As morphology and associated molecular repertoire...
10.
Karan D, Dubey S, Gunewardena S, Iczkowski K, Singh M, Liu P, et al.
Mol Oncol
. 2024 Apr;
18(8):1966-1979.
PMID: 38605607
The androgen receptor (AR) is the main driver in the development of castration-resistant prostate cancer, where the emergence of AR splice variants leads to treatment-resistant disease. Through detailed molecular studies...